ScienceModerna shares surge after experimental mRNA cancer treatment passes key test
Moderna shares more than doubled after the company announced initial results from a study of an experimental cancer treatment, saying the treatment had passed a key test.
T
The Associated Press★★☆☆☆2026-08-19 21:00Original
Moderna shares surge after experimental mRNA cancer treatment passes key test
Science